Christopher Howard Sells 8,486 Shares of Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) Stock

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) Director Christopher Howard sold 8,486 shares of Vivmark Residential Common Shares of Beneficial Interest stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $64.00, for a total transaction of $543,104.00. Following the transaction, the director directly owned 12,730 shares of the company’s stock, valued at $814,720. This represents a 40.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Vivmark Residential Common Shares of Beneficial Interest Stock Performance

Shares of NYSE VMRK traded up $0.38 during mid-day trading on Wednesday, hitting $64.41. 6,131,899 shares of the stock were exchanged, compared to its average volume of 4,406,111. The firm has a market cap of $24.15 billion, a price-to-earnings ratio of 15.77, a PEG ratio of 5.37 and a beta of 0.73. The company has a current ratio of 0.19, a quick ratio of 0.19 and a debt-to-equity ratio of 0.77. Vivmark Residential Common Shares of Beneficial Interest has a twelve month low of $57.57 and a twelve month high of $71.50.

Key Vivmark Residential Common Shares of Beneficial Interest News

Here are the key news stories impacting Vivmark Residential Common Shares of Beneficial Interest this week:

• Positive Sentiment: Stifel Nicolaus maintained a “buy” rating and trimmed its price target only slightly, from $79.00 to $78.50. The target remains well above the recent trading level, signaling continued confidence in Vivmark’s potential. Benzinga article
• Positive Sentiment: Evercore initiated coverage with an “in-line” rating and a $72.00 price target. Although not an outright bullish rating, the target indicates potential appreciation and adds institutional research coverage. Tickerreport article
• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast from $4.06 to $4.07, FY2027 EPS from $4.20 to $4.21, and Q1 2027 EPS from $1.00 to $1.02. These increases suggest slightly improved expectations for near- and medium-term profitability.
• Neutral Sentiment: The analyst consensus still projects steady earnings progression, including approximately $4.40 in FY2028 EPS, but the revisions are small and do not represent a major change to Vivmark’s outlook.
• Negative Sentiment: Zacks lowered estimates for Q3 2026, Q2 2027, Q3 2027, Q1 2028, and FY2028. The FY2028 forecast declined from $4.43 to $4.40, indicating modest pressure on longer-term earnings expectations.

Analysts Set New Price Targets

A number of brokerages have commented on VMRK. Evercore initiated coverage on shares of Vivmark Residential Common Shares of Beneficial Interest in a report on Tuesday. They set an “in-line” rating and a $72.00 price objective on the stock. Stifel Nicolaus dropped their price objective on shares of Vivmark Residential Common Shares of Beneficial Interest from $79.00 to $78.50 and set a “buy” rating for the company in a research report on Wednesday. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $75.25.

About Vivmark Residential Common Shares of Beneficial Interest

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.